- [Resource Hub](/)
- [Resource](/?resource-type=poster#library)
- Multiparameter tissue section imaging and retrieval of image-defined micro-regions for RNA sequencing using the RareCyte platform

# Multiparameter tissue section imaging and retrieval of image-defined micro-regions for RNA sequencing using the RareCyte platform

Multiplex tissue imaging shows where cells sit but not what they are transcribing; this TriCon 2019 poster introduces Pick-Seq, a workflow in which six-color CyteFinder imaging defines micro-regions that the CytePicker module retrieves at 40 µm for RNA sequencing.

Presented by RareCyte / Harvard Medical School.

Read or download to see:

- Six-color whole-slide imaging resolved tumor, T cell and B cell compartments across entire FFPE sections. Tonsil and lung carcinoma sections were stained for CD3, CD4, CD8a, CD20 and cytokeratin alongside a nuclear dye and scanned whole-slide on the CyteFinder Imaging System; tonsil staining separated the crypt lining from the T cell and B cell zones, and lung sections showed cytokeratin-positive carcinoma with infiltrating CD8-positive T cells at 20X.

- Micro-regions picked from image-defined zones at 40 µm returned the expected transcriptional differences. The CytePicker Retrieval Module lifted micro-regions directly from stained frozen tonsil, and RNA sequencing of four T cell zone picks against four follicular picks showed T cell zone upregulation of CD8a, CCL19 and CCL21 with downregulation of CD38, CR2 and CXCL13.

- On FFPE, the sequencing result was carried back to the tissue and confirmed by a second stain. Because antigen retrieval degrades RNA, regions were defined on a stained section and picked from an adjacent DRAQ5-only section; across nine micro-regions CIBERSORT separated T cell zones from follicles, CD21 ran 380 to 1501 FPKM in one follicle against 59 to 120 in the one beside it, and restaining a serial section for CD21 confirmed that difference by immunofluorescence.

[Download poster](https://cdn.sanity.io/files/s3p6uqps/production/65825a0bd90d478bc9af53f3a0ec883e93f349d8.pdf)

Your browser doesn’t support embedded PDFs.
[Download the poster](https://cdn.sanity.io/files/s3p6uqps/production/65825a0bd90d478bc9af53f3a0ec883e93f349d8.pdf) to view it.

[Back to all resources](/#library)
## Related resources
[Article](https://www.selectscience.net/product-news/measuring-versus-reading-transforming-the-field-of-quantitative-pathology?artid=58733) CyteFinder SelectScience
### Measuring versus reading – transforming the field of quantitative pathology
[Read Article](https://www.selectscience.net/product-news/measuring-versus-reading-transforming-the-field-of-quantitative-pathology?artid=58733) [Spec Sheet](https://go.pardot.com/l/455452/2019-11-18/7mzyyz/455452/220141/TS20_103.pdf) CyteFinder
### CyteFinder II HT
[View Spec Sheet](https://go.pardot.com/l/455452/2019-11-18/7mzyyz/455452/220141/TS20_103.pdf) [Spec Sheet](https://go.pardot.com/l/455452/2019-11-18/7mzyz2/455452/220143/TS20_104.pdf) CyteFinder
### CyteFinder II
[View Spec Sheet](https://go.pardot.com/l/455452/2019-11-18/7mzyz2/455452/220143/TS20_104.pdf) [Publication](https://doi.org/10.1200/JCO.2026.44.16_suppl.5041) CyteFinder Journal of Clinical Oncology 2026
### Clinical validation of circulating tumor cell synaptophysin and androgen receptor expression in metastatic prostate cancer phenotypes.
[View Publication](https://doi.org/10.1200/JCO.2026.44.16_suppl.5041) [Video](https://www.youtube.com/watch?v=_oGC1KRVN2U) CyteFinder 2026
### Dr. Pashtoon Kasi on the impact of circulating tumor cells on clinical research
[Watch Video](https://www.youtube.com/watch?v=_oGC1KRVN2U) [Publication](https://doi.org/10.1038/s41587-026-03099-z) CyteFinder Nature Biotechnology 2026
### mRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell expression
[View Publication](https://doi.org/10.1038/s41587-026-03099-z) [Publication](https://pmc.ncbi.nlm.nih.gov/articles/PMC7618831/) CyteFinder Cancer Immunology Research 2026
### Ex Vivo Immuno-Oncology Platform Reveals Spatial T Cell Infiltration Patterns Linked to ATR Inhibition Responses in High-Grade Serous Ovarian Cancer
[View Publication](https://pmc.ncbi.nlm.nih.gov/articles/PMC7618831/) [Publication](https://doi.org/10.1097/pai.0000000000001311) CyteFinder Applied Immunohistochemistry & Molecular Morphology 2026
### Quantitative Assays for TROP2 Measurement in Breast Cancer and Comparison to H-Score
[View Publication](https://doi.org/10.1097/pai.0000000000001311) [Publication](https://pmc.ncbi.nlm.nih.gov/articles/PMC12881594/) CyteFinder Nature Communications 2026
### Extracellular matrix mediates circulating tumor cell clustering in triple-negative breast cancer metastasis
[View Publication](https://pmc.ncbi.nlm.nih.gov/articles/PMC12881594/) [Publication](https://doi.org/10.1016/j.ejso.2025.111357) CyteFinder European Journal of Surgical Oncology 2026
### Circulating tumor cells predict relapse in head and neck mucosal squamous cell carcinoma
[View Publication](https://doi.org/10.1016/j.ejso.2025.111357) [Publication](https://pmc.ncbi.nlm.nih.gov/articles/PMC12805936/) CyteFinder Cancer Research Communications 2026
### Surface Marker Identification to Capture Live Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer
[View Publication](https://pmc.ncbi.nlm.nih.gov/articles/PMC12805936/) [Publication](https://doi.org/10.1158/1078-0432.CCR-25-0244) CyteFinder Clinical Cancer Research 2025
### Pre-clinical Modeling of Navtemadlin Pharmacokinetics, Pharmacodynamics, and Efficacy in IDH-wildtype Glioblastoma
[View Publication](https://doi.org/10.1158/1078-0432.CCR-25-0244)